Augmentation of Nitric Oxide Deficient Hypertension by High Salt Diet Is Associated With Reduced TNF-α Receptor Type 1 Expression in the Kidneys
American Journal of Hypertension · 2024
DOI: 10.1093/ajh/hpae066 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Hypertension, 2024. Verfasst von Dewan S A Majid und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiology, Tulane Hypertension & Renal Center of Excellence, Tulane University School of Medicine, New Orleans, Louisiana 70112, USA. Hauptthemen laut MEDLINE: Receptors, Tumor Necrosis Factor, Type I, Hypertension, Nitric Oxide, Mice, Inbred C57BL. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIGMS NIH HHS.
Abstract (Originalsprache)
BACKGROUND High salt (HS) intake induces an augmented hypertensive response to nitric oxide (NO) inhibition, though it causes minimal changes in blood pressure (BP) in NO intact condition. The cause of such augmentation is not known. HS induces tumor necrosis factor-alpha (TNFα) production that causes natriuresis via activation of its receptor type 1 (TNFR1). We hypothesized that NO deficiency reduces renal TNFR1 activity, leading to enhanced sodium retention and hypertension. METHODS We examined the changes in renal TNFR1 protein expression (Immunohistochemistry analyses) after HS (4% NaCl) intake in wild-type mice (WT, C57BL6) treated with a NO synthase (NOS) inhibitor, nitro-l-arginine methyl ester (L-NAME; 0.05 mg/min/g; osmotic mini-pump), as well as in endothelial NOS knockout mice (eNOSKO) and compared the responses in WT mice with normal salt (NS; 0.3% NaCl) intake. BP was measured with tail-cuff plethysmography and 24-hour urine collections were made using metabolic cages. RESULTS HS alone did not alter mean BP in untreated mice (76 ± 3 to 77 ± 1 mm Hg) but induced an augmented response in L-NAME treated (106 ± 1 vs. 97 ± 2 mm Hg) and in eNOSKO (107 ± 2 vs. 89 ± 3 mm Hg) mice. The percentage area of TNFR1 expression in renal tissue was higher in WT + HS (4.1 + 0.5%) than in WT + NS mice (2.7 ± 0.6%). However, TNFR1 expression was significantly lower in L-NAME treated WT + NS (0.9 ± 0.1%) and in eNOSKO + NS (1.4 ± 0.2%) than in both WT + NS and WT + HS mice. CONCLUSIONS These data indicate that TNFR1 activity is downregulated in NO deficient conditions, which facilitates salt retention leading to augmented hypertension during HS intake.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Physiology, Tulane Hypertension & Renal Center of Excellence, Tulane University School of Medicine, New Orleans, Louisiana 70112, USA.
Förderung
- NIGMS NIH HHS
Zitieren
APA
Majid, D. S. A., Prieto, M. C., Castillo, A., Chamberlain, C., & Navar, L. G. (2024). Augmentation of Nitric Oxide Deficient Hypertension by High Salt Diet Is Associated With Reduced TNF-α Receptor Type 1 Expression in the Kidneys. American Journal of Hypertension. https://doi.org/10.1093/ajh/hpae066
Vancouver
Majid DSA, Prieto MC, Castillo A, Chamberlain C, Navar LG. Augmentation of Nitric Oxide Deficient Hypertension by High Salt Diet Is Associated With Reduced TNF-α Receptor Type 1 Expression in the Kidneys. American Journal of Hypertension. 2024. doi:10.1093/ajh/hpae066
BibTeX
@article{Majid2024,
author = {Majid, Dewan S A and Prieto, Minolfa C and Castillo, Alexander and Chamberlain, Cameron and Navar, Luis Gabriel},
title = {Augmentation of Nitric Oxide Deficient Hypertension by High Salt Diet Is Associated With Reduced TNF-α Receptor Type 1 Expression in the Kidneys},
journal = {American Journal of Hypertension},
year = {2024},
doi = {10.1093/ajh/hpae066}
}
EUVIMED